Siemens resumes oncology shipments

Article

The Oncology Care Systems division of Siemens Medical Systemshas received Food and Drug Administration clearance to resumeshipping and manufacturing in the U.S., the vendor reported lastweek. Siemens halted domestic shipments from the Concord,

The Oncology Care Systems division of Siemens Medical Systemshas received Food and Drug Administration clearance to resumeshipping and manufacturing in the U.S., the vendor reported lastweek. Siemens halted domestic shipments from the Concord, CA,facility last year after FDA audits uncovered problems in manufacturingprocesses at the plant (SCAN 10/12/94).

Siemens received FDA approval on Nov. 2 to resume U.S. shipping,and got the agency's go-ahead in October to manufacture for U.S.customers. The facility has been shipping and manufacturing forinternational customers since March, the company reported. Theplant makes radiation oncology treatment and verification products.

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
Related Content
© 2025 MJH Life Sciences

All rights reserved.